Skip to content

CapEx at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$230.6M+0.6%
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
$10K-58.3%
Omeros logo
OmerosOMER
$0-100%
Vor Biopharma logo
Vor BiopharmaVOR
$48K-79.2%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$11K
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$18K+800%

Other financials

Income statement

See full
Operating income-$46.1M+19.8%
Net income-$44.1M+18.8%
EPS (diluted)-$0.23+37.8%

Balance sheet

See full
Cash & equivalents$175.2M+80.4%
Total debt$25.4M-10.2%
Total equity$204.5M-16.1%
Total assets$262.9M-13.2%

Cash flow

See full
Operating cash flow-$46.8M+6.5%
Free cash flow-$46.8M+6.6%

Valuation

See full
Market cap$868.37M+233%
Enterprise value$718.59M+274%

Returns & leverage

See full
Return on equity-87.6%+42.3pp
Debt / equity0.1×0.0×
Current ratio6.4×-1.6×

Where this comes from

Reported directly by Annexon in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Annexon’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Annexon's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Annexon's capex?
Annexon (ANNX) reported capex of $0 in Q1 2026.
How has Annexon's capex changed year-over-year?
Annexon's capex decreased by 100.0% year-over-year, from $74K to $0.
What is the long-term trend for Annexon's capex?
Over 3 years (2021 to 2025), Annexon's capex has grown at a -56.4% compound annual growth rate (CAGR), from $1.65M to $137K.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.